Health Technology Assessment World Europe 2010

Venue: Millenium Gloucester Hotel

Location: London, United Kingdom

Event Date/Time: Dec 07, 2010 End Date/Time: Dec 10, 2010
Report as Spam


The path for a product to gain market access now involves a fourth hurdle. To jump this hurdle, you need to adapt your market access approaches to different HTA requirements internationally, strengthen outcomes and
cost effectiveness claims and maximise the commercial benefits of your drug along with proving that it is cost effective and adds value.

Health Technology Assessment World Europe 2010 will review country specific HTA now and enable you to find out the latest developments for the appraisal process for Europe, America and Asia allowing you to strengthen
your HEOR data needs.

At Health Technology Assessment World Europe,
you will learn:
• The Latest developments in HTA policy in Europe, USA and Asia
• How to demonstrate comparative effectiveness and outcomes research
• Latest policies in relation to Health Technology Assessment from EUnetHTA, EFPIA and industry
• Emerging interface between regulators and HTA
• Best practice case studies from industry, patient groups and academia

Gaining market access and reimbursement status
involves a thorough grasp of the clinical benefits of your product, an up-to-date handle on methodologies and a comprehensive knowledge of the HTA practice in the markets you are working in. Health Technology Assessment World Europe 2010 can enable you to do this with its excellent speakers, focused content and plentiful networking opportunities.

HTA landscape in Europe is currently changing and evolving and if you want to keep up to date with technology appraisal process then you need to be here.